<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine the efficacy of infliximab treatment in refractory <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease after withdrawal of infusions </plain></SENT>
<SENT sid="1" pm="."><plain>Four patients with <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> secondary to <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease were treated with infliximab until complete remission and were followed after withdrawal of infusions </plain></SENT>
<SENT sid="2" pm="."><plain>Intra-<z:hpo ids='HP_0100533'>ocular inflammation</z:hpo> was assessed using the binocular indirect ophthalmoscopy score, best-corrected visual acuity (BCVA) and foveal thickness measured by optic coherence tomography (OCT) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients included in the study were treated with infliximab for a minimum of 12 months and were in complete remission </plain></SENT>
<SENT sid="4" pm="."><plain>None of the patients were taking steroids or <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Main follow-up after withdrawal of infusions was 7.5 months </plain></SENT>
<SENT sid="6" pm="."><plain>Two out of four patients (50%) maintained complete remission of <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>BCVA was stable in seven eyes </plain></SENT>
<SENT sid="8" pm="."><plain>OCT showed worsening in macular <z:hpo ids='HP_0000969'>edema</z:hpo> in the two eyes of the patients with reactivation </plain></SENT>
<SENT sid="9" pm="."><plain>Infliximab is an efficient long-term treatment for refractory <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Repeated infusions are required to maintain long-term remission which may be sustained on discontinuation of the drug </plain></SENT>
</text></document>